Eugenio Villa

1.2k total citations
20 papers, 973 citations indexed

About

Eugenio Villa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Eugenio Villa has authored 20 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Eugenio Villa's work include Colorectal Cancer Treatments and Studies (5 papers), Glioma Diagnosis and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Eugenio Villa is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Glioma Diagnosis and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Eugenio Villa collaborates with scholars based in Italy, Poland and United States. Eugenio Villa's co-authors include Vanesa Gregorc, Michele Reni, Andrés J.M. Ferreri, Vienna Ludovini, Anna Spreafico, Giovanni Luca Ceresoli, Gianpaolo Balzano, Alessandro Zerbi, Roxann Ingersoll and Jaap Verweij and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Eugenio Villa

20 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eugenio Villa Italy	14	676	396	215	157	114	20	973
Adrian Langleben Canada	17	725 1.1×	416 1.1×	316 1.5×	158 1.0×	167 1.5×	55	1.1k
Jessica Read United Kingdom	9	733 1.1×	514 1.3×	428 2.0×	165 1.1×	247 2.2×	11	1.6k
Yuankai Shi China	14	547 0.8×	395 1.0×	276 1.3×	104 0.7×	123 1.1×	101	997
H. J. Illiger Germany	11	555 0.8×	266 0.7×	386 1.8×	154 1.0×	74 0.6×	28	974
Hwee‐Yong Yap United States	18	765 1.1×	398 1.0×	204 0.9×	174 1.1×	165 1.4×	31	1.3k
Paola Aimone Switzerland	17	549 0.8×	338 0.9×	372 1.7×	135 0.9×	240 2.1×	43	1.1k
M. Wolf Germany	20	801 1.2×	342 0.9×	436 2.0×	85 0.5×	348 3.1×	72	1.3k
Parisa Momtaz United States	14	1.5k 2.2×	362 0.9×	353 1.6×	95 0.6×	150 1.3×	40	1.8k
V. Damiano Italy	15	796 1.2×	568 1.4×	502 2.3×	181 1.2×	63 0.6×	34	1.3k
Yuichi Sakamori Japan	19	1.0k 1.5×	932 2.4×	330 1.5×	146 0.9×	127 1.1×	81	1.5k

Countries citing papers authored by Eugenio Villa

Since Specialization

Citations

This map shows the geographic impact of Eugenio Villa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenio Villa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenio Villa more than expected).

Fields of papers citing papers by Eugenio Villa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugenio Villa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenio Villa. The network helps show where Eugenio Villa may publish in the future.

Co-authorship network of co-authors of Eugenio Villa

This figure shows the co-authorship network connecting the top 25 collaborators of Eugenio Villa. A scholar is included among the top collaborators of Eugenio Villa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenio Villa. Eugenio Villa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Personeni, Nicola, Lorenza Rimassa, Claudio Verusio, et al.. (2015). FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study. Clinical Colorectal Cancer. 14(3). 162–169. 9 indexed citations

Mariucci, S., Sara Delfanti, B. Rovati, et al.. (2012). Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer. Journal of Cancer Research and Clinical Oncology. 138(7). 1187–1196. 27 indexed citations

Milella, Michèle, Alessandra Felici, Giuseppe Di Lorenzo, et al.. (2012). Abstract LB-226: mTOR inhibition by Temsirolimus as second-line treatment for advanced RCC: The Medical optimization of Torisel® (MoTOR) phase II trial by the Italian Kidney Cancer Group (GIR). Cancer Research. 72(8_Supplement). LB–226. 3 indexed citations

Reni, Michele, Stefano Cereda, Michèle Milella, et al.. (2012). Maintenance sunitinib (MS) or observation (O) in metastatic pancreatic adenocarcinoma (MPA): Clinical and translational results of a phase II randomized trial (NCT00967603).. Journal of Clinical Oncology. 30(15_suppl). 4017–4017. 2 indexed citations

Giovannini, Monica, et al.. (2010). Antiangiogenic strategies in breast cancer management. Critical Reviews in Oncology/Hematology. 76(1). 13–35. 18 indexed citations

Carrabba, Matteo Giovanni, Michele Reni, Marco Foppoli, et al.. (2010). Treatment approaches for primary CNS lymphomas. Expert Opinion on Pharmacotherapy. 11(8). 1263–1276. 13 indexed citations

Giovannini, Monica, Vanesa Gregorc, Carmen Belli, et al.. (2009). Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies. Journal of Oncology. 2009(110). 1–8. 35 indexed citations

Krzakowski, Maciej, Mariano Provencio, B. Utracka-Hutka, et al.. (2007). P2-194: Induction chemotherapy (CT) and concomitant chemo-radiotherapy (CT-RT) with vinorelbine oral (NVBo) plus cisplatin (CDDP) in stage III Non-Small Cell Lung Cancer (NSCLC): final results of an international Phase II trial. Journal of Thoracic Oncology. 2(8). S647–S648. 1 indexed citations

Gregorc, Vanesa, Anna Spreafico, Irene Floriani, et al.. (2007). Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer. Cancer. 110(4). 845–853. 32 indexed citations

10.

Ceresoli, Giovanni Luca, Giovanni Mauro Cattaneo, Giovanna Rizzo, et al.. (2007). Role of Computed Tomographyand [¹⁸F] Fluorodeoxyglucose Positron Emission Tomography Image Fusion in Conformal Radiotherapy of Non-Small Cell Lung Cancer: A Comparison with Standard Techniques with and without Elective Nodal Irradiation. Tumori Journal. 93(1). 88–96. 18 indexed citations

11.

Cusatis, George, Vanesa Gregorc, Jing Li, et al.. (2006). Pharmacogenetics of ABCG2 and Adverse Reactions to Gefitinib. JNCI Journal of the National Cancer Institute. 98(23). 1739–1742. 180 indexed citations

12.

Reni, Michele, Stefano Cordio, Carlo Milandri, et al.. (2005). Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial. The Lancet Oncology. 6(6). 369–376. 222 indexed citations

13.

Gregorc, Vanesa, Giovanni Luca Ceresoli, Irene Floriani, et al.. (2004). Effects of Gefitinib on Serum Epidermal Growth Factor Receptor and HER2 in Patients with Advanced Non-Small Cell Lung Cancer. Clinical Cancer Research. 10(18). 6006–6012. 37 indexed citations

14.

Cappuzzo, Federico, Vanesa Gregorc, Elisa Rossi, et al.. (2003). Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC. Journal of Clinical Oncology. 21(14). 2658–2663. 175 indexed citations

15.

Volpe, Aldo Della, Andrés J.M. Ferreri, C. Annaloro, et al.. (2002). Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. International Journal of Radiation Oncology*Biology*Physics. 52(2). 483–488. 86 indexed citations

16.

Ferreri, Andrés J.M., Maurilio Ponzoni, Stefano Cordio, et al.. (1998). Low Sensitivity of Computed Tomography in the Staging of Gastric Lymphomas of Mucosa-Associated Lymphoid Tissue. American Journal of Clinical Oncology. 21(6). 614–616. 4 indexed citations

17.

Zerbi, Alessandro, et al.. (1997). Intraoperative and postoperative radiotherapy in pancreatic cancer. International Journal of Gastrointestinal Cancer. 21(1). 53–58. 18 indexed citations

18.

Reni, Michele, et al.. (1997). Primary brain lymphomas in patients with a prior or concomitant malignancy. Journal of Neuro-Oncology. 32(2). 135–142. 18 indexed citations

19.

Scattoni, Vincenzo, Angelo Bolognesi, Francesco Francesca, et al.. (1996). Neoadjuvant CMV Chemotherapy plus Radical Cystectomy in Locally Advanced Bladder Cancer: The Impact of Pathologic Response on Long-Term Results. Tumori Journal. 82(5). 463–469. 7 indexed citations

20.

Ferreri, Andrés J.M., et al.. (1996). Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion. Cancer. 77(5). 827–833. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact